MediciNova
Price & Volume
Stats
See moreOpen | $1.29 |
Previous Close | $1.25 |
Day Range | $1.27-$1.33 |
52W Range | $1.16-$1.96 |
Market Cap | $60.5M |
Shares Short | 172,764 |
Financials
See moreRevenue (12 Mos) | $596,641 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $47,934 |
Diluted EPS | -$0.23 |
News
See moreYahoo Finance • 9 days ago
Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight
Yahoo Finance • 9 days ago
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
About
CEO | Dr. Yuichi Iwaki M.D., Ph.D. |
CFO | Mr. Jason J. Kruger CPA |
Address | 4275 Executive Square, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |